Skip to main content

Guidance Documents

1272 Results
Guidance Documents

Email Concerning Application Forms

Email to credit counseling agencies and debtor education providers concerning updated application forms.

ID: UST-2043196
Component U.S. Trustee Program
Date Issued: December 29, 2022
Guidance Documents

Credit Counseling Instructions

Credit Counseling Application Instructions for Agencies

ID: UST-1317266
Component U.S. Trustee Program
Date Issued: December 29, 2022
Guidance Documents

Credit Counseling Application

Credit Counseling Application for Agencies

ID: UST-1317271
Component U.S. Trustee Program
Date Issued: December 29, 2022
Guidance Documents

Debtor Education Instructions

Debtor Education Application Instructions for Providers

ID: UST-1317281
Component U.S. Trustee Program
Date Issued: December 29, 2022
Guidance Documents

Open Letter to All FFLs - Dec 2022 - Impact of Final Rule 2021-05F on Partially Complete Polymer80, Lone Wolf, and Similar Semiautomatic Pistol Frames

ATF is issuing this open letter to assist the firearms industry and the public in understanding whether a “partially complete, disassembled, or nonfunctional” frame of a Polymer80, Lone Wolf, or similar semiautomatic, striker-fired pistol (sometimes generally referred to as “Glock-type” pistols) has reached a stage of manufacture...

ID: DOJ-2042721
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: December 27, 2022
Guidance Documents

Electronic Storage of Forms 4473 Ruling

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) authorizes an alternate method or procedure from the provisions of Title 27, Code of Federal Regulations (CFR), Part 478.121, 478.124, 478.129, and 27 CFR 479.131 that require Federal Firearms Licensees (FFLs) to retain the ATF Firearms Transaction Record, Form 4473 (5300.9) (Form 4473), in a paper format.

ID: DOJ-2040786
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: October 20, 2022
Guidance Documents

Changes Pharmacists May Make to Schedule II Paper Prescriptions

This guidance document provides clarification regarding the changes pharmacists may make to schedule II paper prescriptions. This guidance will remain in effect until the Drug Enforcement Administration (DEA) codifies new regulations, or until this guidance is otherwise modified or withdrawn by DEA.

ID: DEA-DC-063
Component Diversion Control Program (DEA)
Date Issued: October 18, 2022